Two drugs that treat prostate cancer may also be effective against leukemia

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood and bone marrow, can affect people of all ages but is the most common type of leukemia in adults.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup